(Q36520797)

English

Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa

scientific article published on April 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

cystic fibrosis

0 references

Pseudomonas aeruginosa

0 references

author name string

Jaffar-Bandjee MC

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Lazdunski A

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Bally M

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Carrère J

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Chazalette JP

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Galabert C

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 April 1995

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Journal of Clinical Microbiology

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

924-929

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

The impact of respiratory viral infections in patients with cystic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

30 September 2017

Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

The contribution of exoproducts to virulence of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Co-existence of colonies with different serotypes and other biological characteristics in clinical isolates of Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

28 June 2018

Direct double antibody sandwich immunoassay for Pseudomonas aeruginosa elastase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

21 September 2018

Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

21 September 2018

Inactivation of human bronchial mucosal proteinase inhibitor by Pseudomonas aeruginosa elastase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

21 September 2018

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=228069

21 September 2018

Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoenzymometric assays for alkaline protease and exotoxin A from Pseudomonas aeruginosa: development and use in detecting exoproteins in clinical isolates from patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrasonic method of sputum homogenization and its application in the study of the enzymic content of sputum

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/7790462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36520797&oldid=1636666805"